Evidence of Artemisinin-Resistant Malaria in Africa.
作者信息
Stokes Barbara H, Ward Kurt E, Fidock David A
机构信息
Columbia University Irving Medical Center, New York, NY
出版信息
N Engl J Med. 2022 Apr 7;386(14):1385-1386. doi: 10.1056/NEJMc2117480.
Abstract
摘要
相似文献
1
Evidence of Artemisinin-Resistant Malaria in Africa.非洲出现青蒿素耐药性疟疾的证据。
N Engl J Med. 2022 Apr 7;386(14):1385-1386. doi: 10.1056/NEJMc2117480.
2
Evidence of Artemisinin-Resistant Malaria in Africa. Reply.非洲青蒿素耐药性疟疾的证据。回复。
N Engl J Med. 2022 Apr 7;386(14):1386. doi: 10.1056/NEJMc2117480.
3
The threat of artemisinin resistant malaria in Southeast Asia.东南亚青蒿素耐药性疟疾的威胁。
Travel Med Infect Dis. 2016 Nov-Dec;14(6):548-550. doi: 10.1016/j.tmaid.2016.11.016. Epub 2016 Nov 30.
4
Malaria and artemisinin derivatives: an updated review.疟疾和青蒿素衍生物：最新综述。
Mini Rev Med Chem. 2013 Nov;13(13):1879-902. doi: 10.2174/13895575113136660097.
5
Artemisinins.青蒿素类
Postgrad Med J. 2005 Feb;81(952):71-8. doi: 10.1136/pgmj.2004.028399.
6
[Review of the use of artemisinin and its derivatives in the treatment of malaria].[青蒿素及其衍生物在疟疾治疗中的应用综述]
J Pharm Belg. 2005;60(1):23-9.
7
A Temporizing Solution to "Artemisinin Resistance".针对“青蒿素耐药性”的一种临时解决方案。
N Engl J Med. 2019 May 30;380(22):2087-2089. doi: 10.1056/NEJMp1901233. Epub 2019 Apr 24.
8
How genomics is contributing to the fight against artemisinin-resistant malaria parasites.基因组学如何助力对抗青蒿素耐药疟原虫。
Acta Trop. 2015 Aug;148:1-7. doi: 10.1016/j.actatropica.2015.04.007. Epub 2015 Apr 21.
9
[Artemisinin and successors].[青蒿素及其衍生物]
Pharm Unserer Zeit. 2005;34(2):95. doi: 10.1002/pauz.200590037.
10
Artemisinin Bioactivity and Resistance in Malaria Parasites.青蒿素在疟原虫中的生物活性与抗药性。
Trends Parasitol. 2019 Dec;35(12):953-963. doi: 10.1016/j.pt.2019.09.005. Epub 2019 Nov 4.
引用本文的文献
1
The burden of malaria in East Africa: prevalence, risk factors, and control strategies.东非疟疾负担：患病率、风险因素及控制策略
Malar J. 2025 Aug 8;24(1):255. doi: 10.1186/s12936-025-05492-6.
2
Malaria: past, present, and future.疟疾：过去、现在与未来。
Signal Transduct Target Ther. 2025 Jun 17;10(1):188. doi: 10.1038/s41392-025-02246-3.
3
Safety of RTS,S/AS01E vaccine for malaria in African children aged 5 to 17 months: A systematic review and meta-analysis of randomized controlled trials.RTS,S/AS01E疫苗用于5至17个月非洲儿童疟疾预防的安全性：随机对照试验的系统评价与荟萃分析
PLOS Glob Public Health. 2025 Jun 16;5(6):e0004387. doi: 10.1371/journal.pgph.0004387. eCollection 2025.
4
The PfK13 G533S mutation confers artemisinin partial resistance in multiple genetic backgrounds of .PfK13基因G533S突变在多种基因背景下赋予青蒿素部分抗性。
Antimicrob Agents Chemother. 2025 Jul 2;69(7):e0016225. doi: 10.1128/aac.00162-25. Epub 2025 May 27.
5
Where is the hard-to-reach population? Spatial analysis from a cross-sectional study on the access to bed net and malaria vaccine in the Lake Victoria Region, Kenya.难以触及的人群在哪里？肯尼亚维多利亚湖地区蚊帐和疟疾疫苗获取情况横断面研究的空间分析。
Malar J. 2025 Feb 12;24(1):42. doi: 10.1186/s12936-025-05280-2.
6
Evaluation of the protective efficacy of OlysetPlus ceiling nets for reduction of malaria incidence in children in Homa Bay County, Kenya: a cluster-randomised controlled study protocol.评估OlysetPlus吊床蚊帐对肯尼亚霍马湾县儿童疟疾发病率降低的保护效果：一项整群随机对照研究方案
BMJ Open. 2025 Jan 30;15(1):e087832. doi: 10.1136/bmjopen-2024-087832.
7
YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates.YAT2150对恶性疟原虫具有不可阻挡的作用，并且对间日疟原虫和利什曼原虫临床分离株具有活性。
Sci Rep. 2025 Jan 23;15(1):2941. doi: 10.1038/s41598-025-85346-y.
8
Artemisinin-resistant malaria.抗青蒿素疟疾
Clin Microbiol Rev. 2024 Dec 10;37(4):e0010924. doi: 10.1128/cmr.00109-24. Epub 2024 Oct 15.
9
A retrospective analysis of drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.对耐药标志物的回顾性分析发现，在乌干达北部无症状感染中，早期（2016/17 年）就出现了 k13 C469Y 突变的高流行率。
Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0157623. doi: 10.1128/aac.01576-23. Epub 2024 Aug 13.
10
Indigenous emergence and spread of C469Y artemisinin-resistant in Uganda.乌干达出现并传播对青蒿素耐药的 C469Y 。
Antimicrob Agents Chemother. 2024 Aug 7;68(8):e0165923. doi: 10.1128/aac.01659-23. Epub 2024 Jul 19.
本文引用的文献
1
Evidence of Artemisinin-Resistant Malaria in Africa.非洲出现青蒿素抗药性疟疾。
N Engl J Med. 2021 Sep 23;385(13):1163-1171. doi: 10.1056/NEJMoa2101746.
2
K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness.非洲和亚洲的 K13 突变影响青蒿素耐药性和寄生虫适应性。
Elife. 2021 Jul 19;10:e66277. doi: 10.7554/eLife.66277.
Zotero 插件